Chris Twitty

2.1k total citations
18 papers, 654 citations indexed

About

Chris Twitty is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Chris Twitty has authored 18 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Chris Twitty's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and Microbial Inactivation Methods (4 papers). Chris Twitty is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and Microbial Inactivation Methods (4 papers). Chris Twitty collaborates with scholars based in United States, Switzerland and China. Chris Twitty's co-authors include Bernard A. Fox, Hong‐Ming Hu, Shawn M. Jensen, Walter J. Urba, Adil Daud, Yuhuan Li, Robert H. Pierce, Mai H. Le, Sandra Aung and Christian Poehlein and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Chris Twitty

18 papers receiving 637 citations

Peers

Chris Twitty
Julie Urban United States
João Paulo Portela Catani Belgium
Estela Noguera-Ortega United States
Cornell Allen United States
Jorge G. Gómez-Gutiérrez United States
John P. Riley United States
Sophia Z. Shalhout United States
Karen O. Allen United States
Yohko Nakagawa Japan
Shirley Bartido United States
Julie Urban United States
Chris Twitty
Citations per year, relative to Chris Twitty Chris Twitty (= 1×) peers Julie Urban

Countries citing papers authored by Chris Twitty

Since Specialization
Citations

This map shows the geographic impact of Chris Twitty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Twitty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Twitty more than expected).

Fields of papers citing papers by Chris Twitty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Twitty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Twitty. The network helps show where Chris Twitty may publish in the future.

Co-authorship network of co-authors of Chris Twitty

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Twitty. A scholar is included among the top collaborators of Chris Twitty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Twitty. Chris Twitty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gujar, Ravindra, Chang Cui, Christine Lee, et al.. (2023). Abstract 6390: N17350 is an emerging therapeutic modality that selectively kills cancer cells and stimulates anti-tumor immunity. Cancer Research. 83(7_Supplement). 6390–6390. 1 indexed citations
2.
Lee, Jack Y., Bianca Nguyen, Anandaroop Mukhopadhyay, et al.. (2022). Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity. Molecular Therapy — Oncolytics. 25. 174–188. 10 indexed citations
3.
Twitty, Chris, Laura A. Huppert, & Adil Daud. (2020). Prognostic Biomarkers for Melanoma Immunotherapy. Current Oncology Reports. 22(3). 25–25. 11 indexed citations
4.
Bhatia, Shailender, Natalie Miller, Rima M. Kulikauskas, et al.. (2019). Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma. Clinical Cancer Research. 26(3). 598–607. 70 indexed citations
5.
Algazi, Alain P., Katy K. Tsai, Lawrence R. Chen, et al.. (2019). Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses. Cancer Immunology Research. 8(2). 246–254. 68 indexed citations
6.
Canton, David A., Shawna A. Shirley, Jocelyn H. Wright, et al.. (2017). Melanoma Treatment with Intratumoral Electroporation of Tavokinogene Telseplasmid (pIL-12, Tavokinogene Telseplasmid). Immunotherapy. 9(16). 1309–1321. 41 indexed citations
7.
Algazi, Alain P., Katy K. Tsai, Michael D. Rosenblum, et al.. (2017). Immune monitoring outcomes of patients with stage III/IV melanoma treated with a combination of pembrolizumab and intratumoral plasmid interleukin 12 (pIL-12).. Journal of Clinical Oncology. 35(7_suppl). 78–78. 4 indexed citations
8.
Lin, Amy, Chris Twitty, Ryan Burnett, et al.. (2016). Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro. Molecular Therapy — Nucleic Acids. 6. 221–232. 13 indexed citations
9.
Algazi, Alain P., Katy K. Tsai, Lawrence R. Chen, et al.. (2016). Abstract CT134: Intratumoral electroporation of plasmid IL-12 can prime response to anti-PD1/PD-L1 blockade in patients with Stage III/IV-M1a melanoma. Cancer Research. 76(14_Supplement). CT134–CT134. 6 indexed citations
10.
Twitty, Chris, Oscar R. Diago, Daniel J. Hogan, et al.. (2015). Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types. Human Gene Therapy Methods. 27(1). 17–31. 27 indexed citations
11.
Yi, Yongxiang, Shu Su, Yuan Fang, et al.. (2012). Autophagy-assisted antigen cross-presentation. OncoImmunology. 1(6). 976–978. 50 indexed citations
12.
Jensen, Shawn M., Chris Twitty, Paul A. Antony, et al.. (2012). Increased Frequency of Suppressive Regulatory T Cells and T Cell-Mediated Antigen Loss Results in Murine Melanoma Recurrence. The Journal of Immunology. 189(2). 767–776. 26 indexed citations
13.
Twitty, Chris, Shawn M. Jensen, Hong‐Ming Hu, & Bernard A. Fox. (2011). Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism. Clinical Cancer Research. 17(20). 6467–6481. 78 indexed citations
14.
Church, S., Shawn M. Jensen, Chris Twitty, et al.. (2011). Multiple Vaccinations. The Cancer Journal. 17(5). 379–396. 9 indexed citations
15.
Jensen, Shawn M., Michael J. Gough, Carl E. Ruby, et al.. (2010). Signaling Through OX40 Enhances Antitumor Immunity. Seminars in Oncology. 37(5). 524–532. 109 indexed citations
16.
Petrausch, Ulf, Shawn M. Jensen, Chris Twitty, et al.. (2009). Disruption of TGF-β Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity. The Journal of Immunology. 183(6). 3682–3689. 27 indexed citations
17.
Li, Yuhuan, Lixin Wang, Puiyi Pang, et al.. (2009). Cross-presentation of tumor associated antigens through tumor-derived autophagosomes. Autophagy. 5(4). 576–577. 51 indexed citations
18.
Farson, Deborah, Thomas C. Harding, Jun Liu, et al.. (2004). Development and characterization of a cell line for large‐scale, serum‐free production of recombinant adeno‐associated viral vectors. The Journal of Gene Medicine. 6(12). 1369–1381. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Urban Breakdown of academic impact, for papers by João Paulo Portela Catani Breakdown of academic impact, for papers by Estela Noguera-Ortega Breakdown of academic impact, for papers by Cornell Allen Breakdown of academic impact, for papers by Jorge G. Gómez-Gutiérrez Breakdown of academic impact, for papers by John P. Riley Breakdown of academic impact, for papers by Sophia Z. Shalhout Breakdown of academic impact, for papers by Karen O. Allen Breakdown of academic impact, for papers by Yohko Nakagawa Breakdown of academic impact, for papers by Shirley Bartido
Rankless by CCL
2026